Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 6070 (MIR6070) is a human microRNA gene encoding a short, single-stranded, non-coding RNA of approximately 20-24 nucleotides. Like other microRNAs, MIR6070 is transcribed by RNA polymerase II, processed from primary transcripts by the Drosha and Dicer enzymes, and incorporated into the RNA-induced silencing complex (RISC). The mature MIR6070 guides RISC to complementary target mRNAs via imperfect base pairing, leading predominantly to translational inhibition or destabilization of those transcripts. MIR6070 belongs to a large family of microRNAs that collectively regulate gene expression post-transcriptionally across diverse cellular and developmental processes. While microRNAs have well-established roles in cancer, cell proliferation, apoptosis, immune regulation, and other diseases, there is currently no evidence that MIR6070 itself is considered a direct therapeutic target, nor are there known drugs or biomarkers specifically interacting with MIR6070[1][3][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 6070 (MIR6070).